From CAR-T approaches to bispecific antibodies, scientists are learning how to guide immune cells directly to cancer. Each clinical trial moves the field a little closer to better, more precise treatments.

#CancerTrials #PrecisionMedicine #CancerScience #TCSC

Opening doors to immunotherapy in prostate cancer: A roadmap from clinic to community - The Cancer Letter Prostate cancer remains a formidable challenge, particularly in its advanced stages, where bone metastases and treatment resistance dominate outcomes. At City of Hope, our focus is on leveraging immun...

The momentum behind immunotherapy continues to build. Researchers are exploring CAR-T and bispecific T-cell therapies designed to help the immune system attack prostate cancer more effectively.

#Immunotherapy #CancerInnovation #CancerResearch #Oncology #TCSC
cancerletter.com/sponsored-ar...

Combining therapies is becoming one of the most powerful strategies in oncology. By activating the immune system while targeting the tumour directly, researchers hope to improve outcomes in early-stage prostate cancer.

#CancerInnovation #Immunotherapy #CancerScience #TCSC

Biotech companies, investors pour billions into mRNA vaccines as research ramps up in cancer and non-communicable diseases - The Cancer Letter After the stunning success of mRNA vaccines during the COVID-19 pandemic, researchers and biotech companies are racing to prove the utility of the technology in an array of non-communicable diseases—i...

Encouraging news in prostate cancer research: pairing next-generation immunotherapy with standard hormone therapy before surgery may help overcome long-standing treatment barriers.

#ProstateCancer #Immunotherapy #CancerResearch #Oncology #TCSC
cancerletter.com/the-cancer-l...

Up to 75% of patients report cognitive issues during chemotherapy. Studies like this show supportive care matters just as much as drugs. Exercise may become part of routine cancer care in the future.

#CancerCare #CancerTreatment #OncologyResearch #TCSC

Can Exercise Help Chemo Brain? New Research Adds Promising Results For patients taking chemotherapy, an exercise "prescription" allowed them to maintain daily steps and stay mentally sharp.

New research suggests something remarkably simple may help reduce “chemo brain.” A structured program of walking and resistance exercises helped patients stay mentally sharper during chemotherapy.

#CancerResearch #ChemoBrain #Oncology #CancerSupport #TCSC
www.urmc.rochester.edu/news/story/c...

Pancreatic cancer is often diagnosed late, making it difficult to treat. Targeting early cellular changes before cancer develops could transform how the disease is prevented and treated. #CancerResearch #EarlyDetection #TCSC

A new research strategy aims to stop #pancreaticcancer before tumours even form. Scientists are exploring ways to eliminate microscopic precancerous lesions, potentially preventing this cancer from developing. #PancreaticCancer #MedicalInnovation #TCSC

www.eurekalert.org/news-release...

BPDCN is a rare blood cancer with limited treatment options. Results like these from early trials offer hope that new targeted therapies could soon improve survival and quality of life. #Hematology #ClinicalTrials #TCSC

Trial highlights promising frontline therapy for blastic plasmacytoid dendritic cell neoplasm Seventy-five percent of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) who were treated with the antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) had a complete response, ac...

A promising antibody-drug conjugate therapy is showing encouraging results in a rare #bloodcancer. In an early trial, 75% of patients with BPDCN achieved a complete response with the investigational treatment pivekimab sunirine. #Leukemia #CancerTreatment #TCSC

www.news-medical.net/news/2026021...

Lynch syndrome significantly increases the risk of several cancers, including colorectal and uterine cancers. Early genetic testing and coordinated care can make a life-saving difference. Awareness matters. #CancerAwareness #GeneticTesting #TCSC

Penn Medicine launches new center dedicated to Lynch syndrome, cancer research Dennis Massimo’s genetic diagnosis and cancer treatment plan was coordinated at the new King Center for Lynch Syndrome at Penn Medicine.

A new centre at Penn Medicine aims to transform care for people with inherited cancer risk. The King Center for Lynch Syndrome will combine #genetics, screening and treatment expertise to catch cancers earlier and improve outcomes. #CancerPrevention #PrecisionMedicine #TCSC

whyy.org/articles/lyn...

Triple-negative breast cancer remains one of the toughest cancers to treat. Discoveries like this could open the door to entirely new therapies. #OncologyResearch #PrecisionMedicine #TCSC

Scientists discover molecule that stops aggressive breast cancer in its tracks Scientists at Oregon Health & Science University have developed a new molecule that could open the door to treating triple-negative breast cancer, one of the most aggressive and difficult-to-treat for...

Scientists have discovered a new molecule that may stop aggressive triple-negative breast cancer in its tracks. Research suggests it can suppress tumour growth by targeting a key cancer enzyme. #BreastCancer #CancerResearch #DrugDiscovery #TCSC

www.sciencedaily.com/releases/202...

Behind every cancer breakthrough are patients and families whose strength pushes medicine forward. Their stories deserve to be heard. #PatientStories #CancerCommunity #TCSC

A Mother, Her Daughter & a Groundbreaking Transplant at Perlmutter Cancer Center NYU Langone’s Perlmutter Cancer Center helped save a mother’s life through a first-of-its-kind bone marrow transplant using healthy cells donated by her daughter.

A remarkable story of family, courage and medical innovation. At NYU Langone’s Perlmutter Cancer Center, a groundbreaking transplant brought new hope to a mother and her daughter facing cancer together. #CancerCare #MedicalInnovation #Hope #TCSC

nyulangone.org/news/mother-...

Key takeaway: small, sustainable changes to weight, diet, and activity can lower risk over time, especially when combined with screening and early detection. Every step counts. #CancerAwareness #PublicHealth #TCSC

Obesity and Cancer: A Translational Science Review This translational science review summarizes current evidence about the primary biologic pathways by which obesity may promote development of cancer and interventions that may reduce obesity-associate...

A new JAMA review explains how obesity biologically drives cancer risk… and how targeting inflammation, hormones, and metabolism could improve prevention and treatment. Hope powered by science. #Cancer #Prevention #TCSC
jamanetwork.com/journals/jam...

For patients with residual disease, better post-neoadjuvant options could help reduce recurrence risk and improve outcomes. Progress matters. #Oncology #BreastCancer #TCSC

Enhertu has been granted US Priority Review for HER2-positive early breast cancer after neoadjuvant treatment. A hopeful step forward for patients with residual disease. #BreastCancer #CancerResearch #TCSC
www.astrazeneca.com/media-centre...

Understanding your cancer and the treatments available is one of the most powerful steps a patient can take. Information helps people navigate the journey with greater confidence. #CancerAwareness #PatientAdvocacy #TCSC

Special Treatment: A Message From the Editor of Cancer Health’s Spring 2026 Issue You want the best outcome after your diagnosis—that much is obvious. But what isn’t so clear is the active role you can play in your care.

Knowledge is power when facing cancer. The Spring 2026 issue of Cancer Health highlights how learning about your diagnosis and treatment options can help patients make more confident decisions about their care. #CancerPatients #CancerCare #HealthEducation #TCSC
www.cancerhealth.com/article/spec...

Cancer treatment is no longer just one tool. Surgery, radiation, chemotherapy and targeted therapies all work together to improve survival and quality of life. Understanding the options empowers patients. #CancerAwareness #TCSC

Chemotherapy has changed dramatically over the years. Today’s treatments are often more targeted, better tolerated and carefully tailored to each patient. #CancerTreatment #Oncology #CancerCare #TCSC
www.mayoclinic.org/tests-proced...

Oncology expert says eat this breakfast food every day to stop killer bowel cancer — The Mirror A scientist has explained how eating it regularly could help reduce the risk, with research showing it may protect against certain types of the disease

A scientist has explained how eating yoghurt regularly could help reduce the risk of aggressive bowel cancer, with research showing it may protect against certain types of the disease!

#Oncology #breakfast #bowelcancer #TCSC
apple.news/AbCnPHVTVS_y...

Innovation in breast cancer treatment continues to accelerate, bringing fresh hope for patients facing difficult diagnoses and limited options.

#BreastCancerAwareness #Oncology #TCSC

Five Under 5: Top Oncology Videos for the Week of 3/1 | OncLive The top 5 OncLive TV videos of the week cover insights in mantle cell lymphoma, breast cancer, bladder cancer, head and neck cancer, and pancreatic cancer.

Triple-negative breast cancer remains one of the most aggressive forms of the disease. Experts continue exploring new treatment approaches and clinical strategies to improve outcomes.

#BreastCancer #TNBC #CancerResearch #TCSC

www.onclive.com/view/five-un...

Pancreatic cancer remains one of the most challenging diseases in oncology. Discoveries like this gene switch could help turn resistant tumors into ones doctors can actually treat.

#PancreaticCancer #CancerScience #TCSC

Breakthrough Discovery Could Make Pancreatic Cancer Respond to Chemo Again A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.

Researchers have discovered a molecular “switch” that may make chemotherapy-resistant pancreatic cancer respond to treatment again. A promising step toward tackling one of the toughest cancers to treat.

#PancreaticCancer #CancerResearch #Oncology #TCSC

scitechdaily.com?p=512575

Science rarely gives simple answers. Discoveries like this help researchers better understand how aging, metabolism and cancer intersect. Each insight brings us closer to smarter prevention and treatment strategies.

#CancerResearch #MedicalScience #TCSC